Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy

被引:40
作者
Saito, Nobue [1 ]
Imai, Yutaka [2 ]
Muto, Takashi [1 ]
Sairenchi, Toshimi [1 ]
机构
[1] Dokkyo Med Univ, Dept Publ Hlth, Sch Med, Shimotsugagun Mibu, Tochigi 3210293, Japan
[2] Dokkyo Med Univ, Dept Oral & Maxillofacial Surg, Sch Med, Shimotsugagun Mibu, Tochigi 3210293, Japan
关键词
Oral cancer; Oral mucositis; Radiotherapy; Risk factors; TREATMENT-RELATED TOXICITY; NECK-CANCER; CHEMOTHERAPY; OUTCOMES; HEAD; CARCINOMA; IMPACT;
D O I
10.1007/s00520-012-1620-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association between body mass index (BMI) and oral mucositis in oral cancer patients receiving radiotherapy is unclear. This study examined whether low BMI could be a risk factor for oral mucositis in oral cancer patients receiving radiotherapy. Between April 2007 and March 2011, a total of 33 inpatients with oral cancer receiving radiotherapy were recruited. They were followed from the beginning of radiotherapy to discharge from hospital. All patients had no mucositis when radiotherapy started. The odds ratio (OR) and 95 % confidence interval (CI) of BMI for incident grade 2 and grade 3 mucositis were calculated by use of univariable logistic regression models. All patients developed oral mucositis (grade 1 in 39.4 %, grade 2 in 30.3 %, grade 3 in 30.3 %), with the maximum grade occurring at an average of 32.4 days. Compared with normal BMI (a parts per thousand yen22.0), the OR of low BMI (< 22.0) for moderate to severe mucositis was 9.07 (95 % CI, 1.72-47.68). Low BMI may be a risk factor of moderate to severe oral mucositis.
引用
收藏
页码:3373 / 3377
页数:5
相关论文
共 50 条
  • [41] The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients
    Liang, Gai
    Du, Wei
    Ke, Qinghua
    Huang, Bing
    Yang, Jiyuan
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03): : 409 - 413
  • [42] Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer
    Anna Vesty
    Kim Gear
    Kristi Biswas
    Brett Wagner Mackenzie
    Michael W. Taylor
    Richard G. Douglas
    [J]. Supportive Care in Cancer, 2020, 28 : 2683 - 2691
  • [43] Severe Oral Mucositis in Pediatric Cancer Patients: Survival Analysis and Predictive Factors
    Leite Damascena, Lecidamia Cristina
    Nobrega de Lucena, Nyellisonn Nando
    Arrais Ribeiro, Isabella Lima
    Pereira, Tarciana Liberal
    Araujo Lima-Filho, Luiz Medeiros
    Gondim Valenca, Ana Maria
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (04)
  • [44] Effect of polaprezinc on oral mucositis, irradiation period, and time to discharge in patients with head and neck cancer
    Suzuki, Akio
    Kobayashi, Ryo
    Shakui, Toshinobu
    Kubota, Yukimasa
    Fukita, Masaharu
    Kuze, Bunya
    Aoki, Mitsuhiro
    Sugiyama, Tadashi
    Mizuta, Keisuke
    Itoh, Yoshinori
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (09): : 1387 - 1392
  • [45] ZINC SUPPLEMENTATION MAY REDUCE THE EFFECTS OF ORAL MUCOSITIS FOR PATIENTS WITH CANCER RECEIVING EITHER CHEMOTHERAPY OR RADIOTHERAPY
    Abt, Elliot
    [J]. JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2020, 20 (04)
  • [46] Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients
    Li, Pei-Jing
    Li, Kai-Xin
    Jin, Ting
    Lin, Hua-Ming
    Fang, Jia-Ben
    Yang, Shuang-Yan
    Shen, Wei
    Chen, Jia
    Zhang, Jiang
    Chen, Xiao-Zhong
    Chen, Ming
    Chen, Yuan-Yuan
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] PHENYLBUTYRATE MOUTHWASH MITIGATES ORAL MUCOSITIS DURING RADIOTHERAPY OR CHEMORADIOTHERAPY IN PATIENTS WITH HEAD-AND-NECK CANCER
    Yen, Sang-Hue
    Wang, Ling-Wei
    Lin, Yi-Hsien
    Jen, Yee-Min
    Chung, Yih-Lin
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1463 - 1470
  • [48] Safety and efficacy of Oro-T oral rinse in oral mucositis during cancer radiotherapy and/or chemotherapy: Cumulative analysis of two studies
    Koushik, Kirthi
    Janaki, M. G.
    Kumawat, Rajesh
    Paramesh, Rangesh
    Palaniyamma, D.
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1503 - +
  • [49] Effects of oral supplementation in the management of oral mucositis in cancer patients: A meta-analysis of randomized clinical trials
    de Meneses, Amanda Gomes
    Normando, Ana Gabriela Costa
    Porto de Toledo, Isabela
    Reis, Paula Elaine Diniz
    Guerra, Eliete Neves Silva
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (02) : 117 - 125
  • [50] Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T &gt; G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients
    Brzozowska, Anna
    Powrozek, Tomasz
    Homa-Mlak, Iwona
    Mlak, Radoslaw
    Ciesielka, Marzanna
    Golebiowski, Pawel
    Malecka-Massalska, Teresa
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (01) : 135 - 143